Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II, Multicenter, Single-Arm Study of MPDL3280A in Patients With PD-L1-Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

Next Previous
X
Search
Trial Profile

A Phase II, Multicenter, Single-Arm Study of MPDL3280A in Patients With PD-L1-Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 28 Apr 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atezolizumab (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms FIR
  • Sponsors Genentech

    • Most Recent Events

    • 06 Apr 2023 Results of pololed analysis from BIRCH, FIR, IMpower130, IMpower131, IMpower150, OAK, and POPLAR trials published in the Oncologist
    • 07 Jun 2022 Results a post hoc analysis of a data pooled from OAK, BIRCH, POPLAR and FIR studies assessed the application of longitudinal CRP levels as dynamic biomarker for advanced non-small cell lung cancer patients treated with anti-PD-(L)1presented at the 58th Annual Meeting of the American Society of Clinical Oncology
    • 08 Sep 2020 According to a National Comprehensive Cancer Network media release, results of a post hoc pooled analysis (n=1548) using individual patient data from atezolizumab monotherapy arms of 4 non-small cell lung cancer clinical trials (OAK, POPLAR, BIRCH, and FIR), were published in the September 2020 issue of JNCCN-Journal of the National Comprehensive Cancer Network.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top